217480 — SD Biotechnologies Co Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
- KR₩55bn
- KR₩61bn
- KR₩34bn
Annual income statement for SD Biotechnologies Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 140,725 | 124,681 | 56,574 | 46,943 | 34,471 |
| Cost of Revenue | |||||
| Gross Profit | 51,560 | 36,201 | 18,360 | 19,797 | 15,161 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 147,564 | 165,983 | 89,678 | 59,021 | 42,884 |
| Operating Profit | -6,839 | -41,302 | -33,105 | -12,078 | -8,412 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -9,235 | -42,109 | -37,872 | -10,033 | -13,050 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9,765 | -45,149 | -37,890 | -10,033 | -13,052 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -8,668 | -43,567 | -72,749 | -4,608 | -14,275 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -8,668 | -43,567 | -72,749 | -4,608 | -14,275 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -359 | -2,243 | -2,292 | -299 | -120 |
| Dividends per Share |